Uncategorized Archives - Page 14 of 87 - PsychedelicNewsWire (PNW)

TuesdayJan 04, 2022 10:39 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Milestone Notice of Allowance for Revolutionary Treatment of Anxiety Disorders

USPTO notice marks important milestone in the expansion of CYBN’s intellectual property portfolio Once issued, patent may have opportunity to cover a broad range of claims Anxiety disorders are one of the most common mental illnesses in the United States Cybin (NEO: CYBN) (NYSE American: CYBN) has taken another step forward in its commitment to progressing Psychedelics to Therapeutics(TM). The biopharmaceutical company has received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”) in regard to its patent application connected to its investigational deuterated psychedelic tryptamine compound for the potential treatment of anxiety disorders (https://ibn.fm/fpjXm). “The receipt of…

MondayJan 03, 2022 1:20 pm

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO Joins Gamechangers LIVE Podcast; Shares Views on the Evolution of the Psychedelics Industry

Delic Corp is a leading psychedelic wellness platform with a business network which includes psychedelic wellness clinics, psilocybin research facilities, a famed psychedelic wellness event, and dedicated media and e-commerce platforms Delic’s CEO, Matt Stang recently joined the Gamechangers LIVE podcast to share his perspective on the development of the psychedelic industry along with Delic’s commercial evolution Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has long been known for its role as a trailblazer of new medicines and treatments in the current environment. Its goal is to…

ThursdayDec 30, 2021 3:45 pm

Washington City Approves Measure to Decriminalize Psychedelic Substances

Last week, the city of Port Townsend became the latest city to decriminalize entheogenic fungi and plants through a measure that was unanimously adopted by the city council of Port Townsend. This Washington State city is the latest city to relax its policy on psychedelic substances. Under the approved measure, laws against natural psychedelic plants including ayahuasca, peyote and magic mushrooms, will be the lowest priority for law enforcement in the city. Natural psychedelic substances are sometimes referred to as entheogenic fungi and plants. The initiative also conveys support for the decriminalization of psychedelic drugs at the federal level. In…

WednesdayDec 29, 2021 11:41 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) to Open 2 New Ketamine Infusion Clinics; Co-Founder and CEO Matt Stang Reveals Investor Relations Efforts

Delic Holdings subsidiary, Ketamine Wellness Centers, announced plans to open two new clinics in the coming weeks The clinics, to be located in Salt Lake City, Utah and Reno, Nevada will take KWC’s total clinic count to 14, forming part of the company’s plan to open 13 new ketamine infusion clinics across the country over the next 18 months Following Delic’s keynote ‘Meet Delic’ conference on Nov. 6-7, CEO Matt Stang announced plans to attend the upcoming HC Wainwright Bioconnect Virtual Conference as well as CEM’s 8th annual AlphaNorth Capital Conference in January 2022 Delic Holdings (CSE: DELC) (OTCQB: DELCF),…

MondayDec 20, 2021 11:53 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), an Undervalued Opportunity for Investment

Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022 Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation.…

FridayDec 17, 2021 9:00 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Announces Ketamine Wellness Centers Partnerships With Veterans Administration; Meet Delic Becomes World’s Largest Psychedelic Conference

Ketamine Wellness Centers (“KWC”) has partnered with the Veterans Administration (“VA”) Community Care Networks in Illinois and Minnesota KWC will provide veterans with ketamine treatments for depression, chronic pain and PTSD at no out-of-pocket cost at these locations Meet Delic was held on November 6 and 7 and became the world’s largest psychedelic wellness event Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, has announced its subsidiary, Ketamine Wellness Centers LLC (“KWC”), has entered two new partnerships with the Veteran Administration (“VA”) Community Care Networks of Illinois and Minnesota. KWC, which…

ThursdayDec 16, 2021 1:53 pm

Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to Conduct Study Investigating Effect of Time on LSD Microdosing

Mind Medicine (NASDAQ: MNMD) (NEO: MMED) (“MindMed”), a psychedelic medicine biotech company, plans to conduct research on how the time of the day during which an individual consumes microdoses of a psychedelic drug impacts the substance’s effects. Microdosing refers to consuming a small dose of a recreational dose of a psychedelic, the most commonly used substances being psilocybin and LSD. The biotech firm announced that its research would focus on assessing and comparing evening and daytime administration of microdoses of LSD. LSD is a psychedelic drug whose effects include intensified emotions, thoughts and sensory perception. For microdoses, small doses are…

WednesdayDec 15, 2021 3:02 pm

Study Opens Door for Future Clinical Trials on Psychedelics for Chronic Pain

Various studies have found that psychedelic substances may be used in the treatment of chronic pain, depression and anxiety, among other indications. Research by Imperial College London looked into the effects of self-medicating psychedelics for the management of chronic pain. While it didn’t evaluate the substances’ effectiveness in treating chronic pain, the study opens the door to different clinical trials that will be carried out in a couple of years. Chronic pain is defined as pain that lasts for more than three months. Estimates show that roughly 20% of the global population lives with chronic pain. Severe and debilitating chronic…

TuesdayDec 14, 2021 3:51 pm

Are Celebrities Helping or Hindering Psychedelics Reform Movement?

The psychedelic renaissance has greatly increased the popularity of psychedelic substances as more research on these substances reveals the numerous benefits they possess. For instance, research has found that psilocybin may be used in the treatment of anxiety while MDMA could be used to manage post-traumatic stress disorder. In the recent past, we have also seen celebrities such as Lil Nas X, Miley Cyrus, Megan Fox and Will Smith speak openly about the use of psychedelics and how the substances have assisted them in overcoming mental health issues. In addition, they revealed how the substances had improved their creative pursuits.…

TuesdayDec 14, 2021 12:37 pm

Meet Delic Sells Out, Becomes World’s Largest Psychedelic Conference

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) held the Meet Delic conference from November 6-7, 2021, in Las Vegas, Nevada The event drew over 2,500 attendees, becoming the largest psychedelic wellness and business conference in the world The event featured over 60 expert speakers and thought leaders, including former NBA champion Lamar Odom and comedian Duncan Trussell Organizers have announced new dates for Meet Delic 2022 in Las Vegas In 2015, famed NBA basketball star Lamar Odom was hospitalized in Las Vegas following a near-death overdose, which resulted in multiple seizures, strokes, and a coma. He would go on to…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized